Furthermore, post-treatment chemokine (C-C motif) ligand 5 (CCL5) increase has been associated with responsiveness to immunotherapy (Imiquimod) in breast cancer skin metastasis (9). Our recent work ...

Making the world smarter, happier, and richer.

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

The global fight against cancer is at a pivotal moment. A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine. This revolutionary ...

Messenger RNA (mRNA) vaccines offer an adaptable and scalable platform for cancer immunotherapy, requiring optimal design to elicit a robust and targeted immune response. Recent advancements in ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

Here, we investigated the relative contributions of the CCL2/CCR2 versus CCL5/CCR5 chemokine axes in OA pathogenesis. Results Mice lacking CCL2 or CCR2, but not CCL5 or CCR5, were protected against OA ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Signup now for our FREE acclaimed racial justice newsletters. This means that the mRNA in the vaccine falls apart harmlessly in our bodies once it has done its job and does not affect our own DNA ...